The DOI matches its Crossref record.
Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy
Open accessAbstract
BACKGROUND: Cerebral palsy is the commonest cause of severe physical disability in childhood. For many years treatment has centred on the use of physiotherapy and orthotics to overcome the problems of leg spasticity, which interferes with walking and can lead to limb deformity. Intramuscular botulinum toxin (BT-A) offers a targeted form of therapy to reduce spasticity in specific muscle groups. AIMS: To determine whether intramuscular BT-A can improve walking in children with cerebral palsy. DESIGN: Randomised, double blind, placebo controlled trial. METHODS: Forty patients with spastic diplegia or hemiplegia were enrolled. Twenty two received botulinum toxin and 18 received placebo. The primary outcome measure was video gait analysis and secondary outcome measures were gross motor function measure (GMFM), physiological cost index (PCI), and passive ankle dorsiflexion. RESULTS: Video gait analysis showed clinically and statistically significant improvement in initial foot contact following BT-A at six weeks and 12 weeks compared to placebo. Forty eight per cent of BT-A treated children showed clinical improvement in VGA compared to 17% of placebo treated children. The GMFM (walking dimension) showed a statistically significant improvement in favour of the botulinum toxin treated group. Changes in PCI and passive ankle dorsiflexion were not statistically significant. CONCLUSION: The study gives further support to the use of intramuscular botulinum toxin type A as an adjunct to conventional physiotherapy and orthoses to reduce spasticity and improve functional mobility in children with spastic diplegic or hemiplegic cerebral palsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Simpson, D. M., Blitzer, A., Brashear, A., Comella, C., Dubinsky, R., Hallett, M., Jankovic, J., Karp, B., Ludlow, C. L., Miyasaki, J. M., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000311389.26145.95 · Cited by 618
Koman, L. A., Smith, B. P., & Shilt, J. S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16207-7 · Cited by 459
The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy
Heinen, F., Desloovere, K., Schroeder, A. S., Berweck, S., Borggraefe, I., van Campenhout, A., Andersen, G. L., Aydin, R., Becher, J. G., Bernert, G., et al. (2010) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2009.09.005 · Cited by 296
Borggraefe, I., Schaefer, J. S., Klaiber, M., Dabrowski, E., Ammann-Reiffer, C., Knecht, B., Berweck, S., Heinen, F., & Meyer-Heim, A. (2010) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2010.01.002 · Cited by 169
Bandholm, T., Jensen, B. R., Nielsen, L. M., Rasmussen, H., Bencke, J., Curtis, D., Pedersen, S. A., & Sonne-Holm, S. (2012) · NeuroRehabilitation · doi:10.3233/nre-2012-0756 · Cited by 27
Metadata
- Authors
- Ubhi, T.
- Venue
- Archives of Disease in Childhood
- Publisher
- BMJ
- Published
- 2000-12-01
- Volume
- 83
- Issue
- 6
- Pages
- 481-487
- ISSN
- 0003-9888 (ISSN-L)
- OpenAlex
- W2119749887
- Cited by
- 238
- References
- 0
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. https://app.cochat.ai/papers/10.1136/adc.83.6.481
- The paper
- Ubhi, T. (2000). Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Archives of Disease in Childhood. https://doi.org/10.1136/adc.83.6.481
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.